CUSIP: 78472W104
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,653,635
-
Share change
-
-556,582
-
Total reported value
-
$9,368,585
-
Price per share
-
$0.74
-
Number of holders
-
35
-
Value change
-
-$559,029
-
Number of buys
-
9
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 78472W104?
CUSIP 78472W104 identifies SQZB - SQZ BIOTECHNOLOGIES CO - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 78472W104:
Institutional Holders of SQZ BIOTECHNOLOGIES CO - COM (SQZB) as of Q4 2022
As of 31 Dec 2022,
SQZ BIOTECHNOLOGIES CO - COM (SQZB) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,653,635 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, AMERICAN INTERNATIONAL GROUP, INC., Artal Group S.A., 683 Capital Management, LLC, MAVERICK CAPITAL LTD, STIFEL FINANCIAL CORP, VANGUARD GROUP INC, Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, and RBF Capital, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.